autoregulation and normalization of CBF without induced hypertension.
Introduction
Delayed ischemic manifestations attributable to cerebral vasospasm develop in 30% of patients following aneurysmal subarachnoid haemorrhage (SAH) and usually occur within three to five days of the initial bleed 1-4 . Angiographic vasospasm is characterized by the nonocclusive narrowing of large capacitance vessels at the base of the brain and decreased blood flow in territories distal to the spastic arteries, thereby placing the brain at risk of ischemic injury. Symptomatic vasospasm, which can persist for 15 to 28 days following the initial haemorrhage, often occurs in conjunction with a loss of normal cerebral autoregulation 4-8 . Autoregulatory impairment causes cerebral perfusion to be passively dependent on systemic blood pressure, furthering the risk of ischemic injury.
Summary
Hyperdynamic therapy, consisting of hypervolemia, haemodilution, and hypertension, is an established treatment for cerebral vasospasm following subarachnoid haemorrhage. Angioplasty has emerged as an additional, effective treatment for symptomatic vasospasm. Loss of autoregulation, however, can occur despite effective angioplasty, underscoring the need for treatment with hyperdynamic therapy in combination with angioplasty.
A 43-year-old woman underwent endovascular coiling of a ruptured left posterior communicating artery aneurysm. The patient went on to develop symptomatic vasospasm and was treated with hyperdynamic therapy and angioplasty.
Autoregulation was assessed with xenon CT cerebral blood flow (CBF) measurement. An initial CBF study was obtained when the patient received dopamine and dobutamine infusions to maintain systolic blood pressure at 160 mmHg. The vasopressor drips were then temporarily held for twenty minutes, allowing the patient's systolic blood pressure to drop to 140 mmHg, and a repeat CBF study was obtained. Several days after angioplasty, CBF decreased significantly when the patient was taken off vasopressors, indicating impaired autoregulation. Hyperdynamic therapy was continued, and another CBF study one week later showed a return of Hyperdynamic therapy, consisting of volume expansion, haemodilution, and induced hypertension, is a first-line treatment for symptomatic vasospasm 9-11 .
Hyperdynamic therapy can optimize blood flow through spastic cerebral vessels and protect against diminished cerebral perfusion secondary to abnormal autoregulation. In recent years, transluminal balloon angioplasty has emerged as an effective treatment for angiographic vasospasm 12-14 .
This case report illustrates the use of quantitative cerebral blood flow (CBF) measurement in the management of cerebral vasospasm complicated by loss of autoregulation despite angiographically successful angioplasty. It underscores the importance of distinguishing angiographic vasospasm and impaired autoregulation as distinct pathophysiologic processes that can contribute to ischemic injury following aneurysmal SAH.
Case Report
A 43-year-old woman with a history of hypertension suffered a sudden severe headache, seizure, and depressed level of consciousness. On presentation in the emergency room, she was combative and not able to follow commands. A head CT showed subarachnoid haemorrhage and hydrocephalus. After placement of a ventriculostomy, a cerebral angiogram was obtained, demonstrating a left posterior communicating artery aneurysm. The aneurysm was treated with deployment of Gugliemi detachable coils, and follow-up angiography showed tight packing of the aneurysm lumen with preservation of the parent arteries. Treatment with nimodipine (60 mg by nasogastric tube every four hours) was begun.
The patient made gradual progress following ventriculostomy and endovascular treatment of the ruptured aneurysm, and she became in- pressor drips were held and the systolic blood pressure was allowed to fall to 140 mmHg, the average cortical mantle CBF was 23 ml/100gm/min (figure 2, right). This significant fall in CBF with a drop in blood pressure was an indication of loss of autoregulation, and the dopamine and dobutamine drips were resumed.
Several days later on post-haemorrhage day 18, a repeat xenon CT blood pressure challenge was done. Cortical mantle CBF averaged 30 ml/100gm/min both in the presence (dopamine infusion at 5.7 mcg/kg/min) and absence of vasopressor support (figure 3), indicating restoration of cerebral autoregulation. The dopamine drip was discontinued, and the patient shortly thereafter was able to be extubated, and the ventriculostomy was removed. Her neurological status continued to progress, with a significant improvement in her level of consciousness and resolution of the hemiparesis.
Discussion
While delayed symptomatic ischemia affects 20-30% of patients following SAH 1,2 , angiographically apparent cerebral vasospasm occurs in up to 70% of SAH patients and is associated with decreased regional CBF 2,15,16 . Hyperdynamic therapy 9,11 and percutaneous transfemoral balloon angioplasty 12-14 improve CBF through large spastic arteries in patients who demonstrate evidence of delayed ischemia due to vasospasm. Although vasospasm of major basal and cortical vessels can contribute to ischemia after SAH, angiographic vasospasm correlates poorly with global CBF reduction 17 and cerebral infarction after SAH 18 . In addition, clinically significant ischemia may occur in territories in which no vasospastic narrowing is apparent 19, 20 . Such discrepancies between the presence of angiographic vasospasm and clinically significant symptomatic ischemia suggest that factors other than large artery narrowing can lead to ischemia after SAH.
Autoregulatory disturbance can occur following SAH and during cerebral vasospasm 4-8 and is likely to contribute to delayed symptomatic ischemia 21 . Autoregulation normally functions to maintain a constant level of CBF over a wide span of systemic blood pressures ranging from 60 mmHg to 160 mmHg 22 . This is accomplished through local alterations in the diameter of cerebral arterioles that control creasingly alert over the ensuing several days. On post-haemorrhage day nine she had an abrupt worsening in her mental status with the development of a right hemiparesis. A xenon CT CBF study demonstrated a CBF level in the left frontal lobe of 9 ml/100gm/min, indicating ischemia (figure 1, left). A cerebral angiogram showed multiple areas of severe vasospasm involving segments of the left supraclinoid internal carotid artery, left anterior and middle cerebral arteries, A1 segment of the right anterior cerebral artery, basilar artery, and right and left posterior cerebral arteries (figure 1, right). A 2.5-French, 4.1 × 10 mm diameter Endeavor balloon catheter (Target Therapeutics/Boston Scientific Corp., Fremont, CA) was introduced over a 0.014 inch Taper guidewire (Target Therapeutics/Boston Scientific Corp.) and used for intracranial angioplasty of the M2 segment of the left middle cerebral artery, left supraclinoid internal carotid artery, M1 segment of the right middle cerebral artery, right supraclinoid internal carotid artery, as well as for angioplasty of the basilar artery, P1 and P2 segments of the left posterior cerebral artery, and distal right vertebral artery. In addition, a 2 × 10 mm Stealth balloon catheter (Target Therapeutics/Boston Scientific Corp.) was advanced over a 0.016 inch Headliner guidewire (Target Therapeutics/Boston Scientific Corp.) and used for angioplasty of the A1 segment of the left anterior cerebral artery. Follow-up selective arteriograms showed greatly improved flow through the angioplastied vessels, with virtually complete restoration of vessel caliber along all of the treated segments. Hyperdynamic therapy was also initiated, which included intravascular volume expansion, as well as vasopressor support consisting of dopamine and dobutamine drips to maintain systolic blood pressure above 160 mmHg.
After angioplasty and the initiation of hyperdynamic therapy, the patient's level of consciousness improved. On post-haemorrhage day 13, a xenon CT blood pressure challenge study was performed to determine if hyperdynamic therapy was still required to maintain adequate cerebral perfusion. With a dopamine infusion of 11.3 mcg/kg/min and a dobutamine infusion of 8.5 mcg/kg/min used to maintain the patient's systolic blood pressure at 170 mmHg, the CBF in the cortical mantle averaged 39 ml/100gm/min (figure 2, left). After the vaso-cerebrovascular resistance. When autoregulation is impaired, changes in arterial pressure are not adequately compensated for by arteriolar vasodilation or constriction; consequently, cerebral blood flow will vary directly with systemic arterial blood pressure 23 . Following SAH, the autoregulatory curve shifts to the right, making patients more vulnerable to cerebral hypoperfusion and ischemia in response to small decreases in mean arterial blood pressure 24,25 . Experimental studies in animal models of SAH have demonstrated that cerebral autoregulation is intact during the initial haemorrhage 26 , but shortly thereafter may become impaired in the acute stage of SAH 27-31 . Prolonged disturbances in autoregulation can also persist in the chronic phase of SAH, weeks after the initial haemorrhage 32,33 .
Although patients who develop vasospasm often also have underlying impairments in autoregulation, a clear correlation between angiographic vasospasm, which involves large capacitance arteries, and autoregulatory dysfunction, which affects small resistance vessels such as pial arterioles, has not been established. Some evidence suggests that cerebral vasospasm is a cause of disturbed autoregulation. In a primate model of chronic vasospasm, impaired autoregulation coincided with the development of vasospasm and was localized to those cerebral territories perfused by the angiographically-apparent vasospastic arteries 34 . Yundt and colleagues found that autoregulatory vasodilation of cerebral parenchymal resistance vesselswhich normally occurs in response to reduced cerebral perfusion pressure -was impaired in patients with severe large artery vasospasm, yet preserved under comparable conditions of tissue hypoxia in patients with ischemic disease secondary to carotid occlusion 8 . However, other studies suggest that there is no direct correlation between angiographic vasospasm and impaired autoregulation. In a study of patients with SAH, Lang and coworkers found that cerebral autoregulatory impairment could occur prior to and in the absence of cerebral vasospasm 35 .
In a rat model of SAH, derangements in autoregulation can persist long after the time period during which angiographic vasospasm occurs 25 . These results support the idea that impaired autoregulation and angiographic vasospasm can occur independently of one anoth-er or co-exist as two separate pathophysiologic entities.
The present case documents the persistence of autoregulatory dysfunction despite successful endovascular treatment for cerebral vasospasm following SAH. The use of transluminal balloon angioplasty to mechanically dilate large spastic arterial segments in patients with symptomatic ischemia after SAH has been shown to restore the normal angiographic caliber of treated arteries, with clinical improvements in 60% to 80% of patients within hours of the procedure 20 . Although angioplasty in our patient improved CBF through the treated arterial segments, underlying haemodynamic impairments in autoregulation involving the distal parenchymal circulation did not resolve with endovascular therapy. This case supports the hypothesis that large artery vasospasm and dysfunctional parenchymal vessel autoregulation are two distinct processes. Thus, each process must be detected, monitored, and managed as separate entities.
The risk of inadequate CBF that accompanies a loss in autoregulation, even after successful reversal of angiographic arterial narrowing, mandates that CBF be maintained at adequate levels during the period of autoregulatory dysfunction. Hyperdynamic therapy, including induced hypertension, can increase CBF and develop collateral circulation to ischemic regions 5, [36] [37] [38] . In a study utilizing xenon CT CBF measurements in patients with SAH, the minimum threshold flow required for tissue viability was found to be 15 cc/100gm/min, with mild to moderate neurological deficits associated with CBF levels of less than 25 or 20 cc/100gm/min, respectively 19 . Similarly, other authors have found that mean CBF maintained at or above 30 cc/100 gm/min in patients with vasospasm is well tolerated without any neurological sequelae 39 .
Our patient received a 21-day course of the calcium channel antagonist nimodipine. Some experimental evidence indicates that nimodipine may impair cerebral autoregulation by decreasing arteriolar smooth muscle contractility 40 . However, other authors have found that autoregulation is preserved during treatment with nimodipine 41 . Furthermore, nimodipine seems to have a direct neuroprotective effect against ischemia 42 . Data from clinical trials of nimodipine showing improved neurological outcomes following SAH [43] [44] [45] [46] [47] [48] [49] indicate that any deleterious effects of nimodipine on autoregulation are likely to be offset by other beneficial effects.
The confounding effects of different drugs and other clinical factors on cerebral autoregulation underscore the importance of quantitative CBF measurement in guiding hyperdynamic therapy after SAH. This is particularly important during treatment with dopamine, since the drug can have variable effects on CBF. Darby and colleagues observed that while dopamine-induced hypertension improved CBF to ischemic regions after SAH, there was a paradoxical reduction in regional CBF in nonischemic regions in some patients 5 . In addition, the effect of dopamine on CBF varies with dose. At low doses (5 mcg/kg/min) dopamine causes a vasodilatory response in pial arterioles 50, 51 and improves CBF to ischemic regions in patients with SAH 52 . At higher dos-es, however, dopamine can cause an adrenergic and serotonin receptor-mediated vasoconstriction of pial arterioles 53 .
Quantitative CBF measurements provide a means to monitor the response to hyperdynamic therapy in SAH patients with impaired cerebral autoregulation whose angiographic vasospasm has resolved. In the present case, vasopressor support was used to induce hypertension and maintain the patient's mean CBF at approximately 30 cc/100gm/min, as verified by xenon CT CBF studies. Recovery of autoregulation was confirmed on post-haemorrhage day 18, when a repeat xenon CT CBF study demonstrated normal CBF levels of 30 cc/100gm/min in both the presence and absence of vasopressors.
The return of normal cerebral autoregulation thus provided a definitive endpoint for hyperdynamic therapy. 
